PTPRC and neoplasm: Metastatic tumour cell homing was reduced by application of FX+/+CD45+HepELs or FX+/−NK1.1+HepELs compared with the corresponding HepELs from FX−/− livers in tumour‐bearing FX−/− mouse lungs (Appendix Fig S9).